Resveratrol Inhibits Inflammatory Responses via the Mammalian Target of Rapamycin Signaling Pathway in Cultured LPS-Stimulated Microglial Cells
Figure 2
Effects of resveratrol on the cell viability of BV-2 microglial cells.
BV-2 cells were treated with 25, 50, and 100 µM of resveratrol without LPS treatments or with 1 µg/ml LPS or with 10 nM rapamycin treatments for 18 h. BV-2 cells viabilities were measured and expressed as mean ± SEM for three independent experiments.